ArticlePeerJ2023
Foxa2 attenuates steatosis and inhibits the NF-κB/IKK signaling pathway in nonalcoholic fatty liver disease.
Li Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticlePeerJ2023
Li Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.